X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (51) 51
humans (29) 29
respiratory system (29) 29
female (26) 26
male (26) 26
aged (24) 24
middle aged (23) 23
oncology (20) 20
chemotherapy (18) 18
cancer (17) 17
lung cancer (16) 16
aged, 80 and over (14) 14
prognosis (14) 14
diagnosis (13) 13
lung cancer, non-small cell (13) 13
medical colleges (13) 13
respiratory tract diseases (13) 13
adult (12) 12
care and treatment (12) 12
lung diseases (12) 12
patients (12) 12
research (12) 12
carboplatin (11) 11
lung neoplasms - drug therapy (11) 11
pneumonia (11) 11
chronic obstructive pulmonary disease (10) 10
computed tomography (10) 10
analysis (9) 9
carcinoma, non-small-cell lung - drug therapy (9) 9
fibrosis (9) 9
medicine & public health (9) 9
multidisciplinary sciences (9) 9
retrospective studies (9) 9
confidence intervals (8) 8
interstitial lung disease (8) 8
lung neoplasms - pathology (8) 8
medicine (8) 8
non-small-cell lung cancer (8) 8
pharmacology & pharmacy (8) 8
survival (8) 8
treatment outcome (8) 8
antimitotic agents (7) 7
antineoplastic agents (7) 7
asthma (7) 7
biopsy (7) 7
carcinoma, non-small-cell lung - pathology (7) 7
cardiac & cardiovascular systems (7) 7
corticosteroids (7) 7
disease (7) 7
double-blind (7) 7
internal medicine (7) 7
multivariate analysis (7) 7
pulmonary fibrosis (7) 7
science (7) 7
therapy (7) 7
antibodies (6) 6
cancer research (6) 6
copd (6) 6
docetaxel (6) 6
health aspects (6) 6
idiopathic pulmonary-fibrosis (6) 6
immunology (6) 6
lung cancer, small cell (6) 6
maintenance therapy (6) 6
medical research (6) 6
nausea (6) 6
obstructive pulmonary-disease (6) 6
pharmacology/toxicology (6) 6
prevention (6) 6
pulmonary/respiratory (6) 6
rheumatology (6) 6
risk factors (6) 6
studies (6) 6
toxicity (6) 6
acute exacerbation (5) 5
adenocarcinoma (5) 5
aprepitant (5) 5
autoantibodies (5) 5
bevacizumab (5) 5
biomarkers - blood (5) 5
bronchus (5) 5
chemotherapy-induced nausea and vomiting (5) 5
cisplatin (5) 5
dermatomyositis (5) 5
disease progression (5) 5
emphysema (5) 5
hematology, oncology and palliative medicine (5) 5
idiopathic pulmonary fibrosis (5) 5
medical prognosis (5) 5
medicine, experimental (5) 5
pemetrexed (5) 5
physiological aspects (5) 5
s-1 (5) 5
severity of illness index (5) 5
trial (5) 5
abridged index medicus (4) 4
age (4) 4
amyopathic dermatomyositis (4) 4
antineoplastic agents - adverse effects (4) 4
antineoplastic agents - therapeutic use (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Respiratory Medicine Case Reports, ISSN 2213-0071, 2017, Volume 20, Issue C, pp. 160 - 163
Abstract MET is a driver oncogene in non-small-cell lung cancer (NSCLC), and its amplification is associated with acquired resistance to epidermal growth... 
Internal Medicine | Pulmonary/Respiratory | Crizotinib | Resistance | Non-small-cell lung cancer | MET amplification | Erlotinib
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 58, pp. 30 - 37
Abstract Objectives Single agent maintenance therapy is widely accepted for advanced non-squamous non small cell lung cancer (NSCLC). However, there is no... 
Hematology, Oncology and Palliative Medicine | Carboplatin | Maintenance therapy | Non small cell lung cancer | Pemetrexed | Bevacizumab | PLUS CARBOPLATIN | DOCETAXEL | CHEMOTHERAPY | GEMCITABINE | TRIAL | CISPLATIN | ONCOLOGY | RANDOMIZED PHASE-III | VASCULATURE | LINE THERAPY | NORMALIZATION | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Bevacizumab - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Lung Neoplasms - pathology | Male | Feasibility Studies | Carboplatin - adverse effects | Time Factors | Adult | Female | Maintenance Chemotherapy | Carcinoma, Non-Small-Cell Lung - pathology | Bevacizumab - administration & dosage | Drug Administration Schedule | Japan | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Remission Induction | Disease-Free Survival | Pemetrexed - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pemetrexed - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Antimitotic agents | Medical colleges | Care and treatment | Therapeutics | Lung cancer, Small cell | Respiratory agents | Lung cancer, Non-small cell | Antineoplastic agents | Homeopathy | Materia medica and therapeutics
Journal Article
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ISSN 1178-2005, 2019, Volume 14, pp. 1867 - 1877
Journal Article
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2016, Volume 115, pp. 46 - 52
Abstract Background Mac-2 binding protein (M2BP) is a cell-adhesive glycoprotein of the extracellular matrix secreted as a ligand of galectin-3 (Mac-2).... 
Pulmonary/Respiratory | Mac-2 binding protein (M2BP) | Biomarker | Mac-2 binding protein glycosylation isomer (M2BPGi) | Wisteria floribunda agglutinin positive-M2BP (WFA+-M2BP) | Idiopathic pulmonary fibrosis (IPF) | M2BP | Wisteria floribunda agglutinin positive-M2BP (WFA | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | RING-LIKE STRUCTURES | MAC-2-BINDING PROTEIN | FIBROBLASTIC FOCI | USUAL INTERSTITIAL PNEUMONIA | BIOMARKERS | GALECTIN-3 | THERAPY | HEPATITIS | RESPIRATORY SYSTEM | Wisteria floribunda agglutinin positive-M2BP (WFA(+)-M2BP) | TUMOR-ASSOCIATED ANTIGEN | Severity of Illness Index | Prognosis | Humans | Middle Aged | Membrane Glycoproteins - blood | Plant Lectins - blood | Male | Biomarkers - blood | Idiopathic Pulmonary Fibrosis - metabolism | Antigens, Neoplasm - blood | Liver Cirrhosis - metabolism | Idiopathic Pulmonary Fibrosis - pathology | Liver Cirrhosis - pathology | Female | Aged | Receptors, N-Acetylglucosamine - blood | Lectins | Medical colleges | Respiratory tract diseases | Pulmonary fibrosis | Liver | Protein binding | Analysis | Health care | Immunoassay | Pneumonia | Health promotion | Preventive medicine | Multivariate analysis | Cell adhesion & migration | Proteins | Confidence intervals | Pathology | Hepatitis | Biopsy | Rodents | Medical prognosis | Biomarkers | Tomography | Carbon monoxide
Journal Article
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ISSN 1178-2005, 2019, Volume 14, pp. 1333 - 1342
Purpose: The diagnosis and severity of chronic obstructive pulmonary disease (COPD) are defined by airflow limitation using spirometry. However, COPD has... 
phenotype | WALL THICKNESS | airway | FLOW LIMITATION | RESPIRATORY IMPEDANCE | CLUSTER-ANALYSIS | emphysema | COPD PHENOTYPES | three-dimensional computed tomography | RESPIRATORY SYSTEM | CHEST CT | IMPULSE OSCILLOMETRY | THIN-SECTION CT | SMALL-AIRWAY OBSTRUCTION | clustering analysis | chronic obstructive pulmonary disease
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 10/2018, Volume 13, Issue 10, pp. S400 - S401
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 7818 - 8
Overlap of asthma and COPD has attracted attention recently. We aimed to clarify physiological and morphological differences of the airways between COPD and... 
LUNG | DIMENSIONS | OBSTRUCTIVE PULMONARY-DISEASE | IMPEDANCE | MULTIDISCIPLINARY SCIENCES | EMPHYSEMA | IMPULSE OSCILLOMETRY | FORCED OSCILLATION TECHNIQUE | RESPIRATORY RESISTANCE | REACTANCE | COMPUTED-TOMOGRAPHY | Computed tomography | Morphology | Bronchus | Physiology | Chronic obstructive pulmonary disease | Respiration | Asthma | Smoking
Journal Article
Lung Cancer, ISSN 0169-5002, 2014, Volume 84, Issue 3, pp. 259 - 264
Abstract Objectives Chemotherapy-induced nausea and vomiting (CINV) is an unanswered problem in cancer therapy. We evaluated the efficacy and safety of triple... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | Aprepitant | Carboplatin | Non-small-cell lung cancer | Pemetrexed | Antiemetic | Chemotherapy-induced nausea and vomiting | INDUCED NAUSEA | DEXAMETHASONE | ANTAGONIST APREPITANT | EFFICACY | PREVENTION | THERAPY | ONCOLOGY | RESPIRATORY SYSTEM | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | HIGH-DOSE CISPLATIN | QUALITY-OF-LIFE | Lung Neoplasms - drug therapy | Serotonin - administration & dosage | Glutamates - adverse effects | Nausea - chemically induced | Guanine - analogs & derivatives | Humans | Middle Aged | Antiemetics - administration & dosage | Male | Carboplatin - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Guanine - adverse effects | Drug Therapy, Combination | Vomiting - prevention & control | Dexamethasone - administration & dosage | Morpholines - administration & dosage | Carboplatin - administration & dosage | Nausea - prevention & control | Vomiting - chemically induced | Glutamates - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Guanine - administration & dosage | Antimitotic agents | Medical colleges | Evaluation | Care and treatment | Chemotherapy | Corticosteroids | Gastrointestinal agents | Nausea | Lung cancer, Non-small cell | Antineoplastic agents | Health aspects | Cancer
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 01/2017, Volume 19, Issue 1, p. 9
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 07/2019, Volume 9, Issue 1, pp. 10484 - 9
Weight loss progresses with the progression of idiopathic pulmonary fibrosis (IPF), and acute exacerbation of IPF (AE-IPF) frequently occurs in its advanced... 
SYSTEM | LUNG | EXPRESSION | MULTIDISCIPLINARY SCIENCES | LIVER FIBROSIS | Adipose tissue | C-reactive protein | Lung diseases | Body weight loss | Multivariate analysis | Patients | Adiponectin | Body mass index | Pulmonary fibrosis | Medical prognosis | Leptin | Fibrosis | Enzyme-linked immunosorbent assay
Journal Article